http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104224710-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24 |
| filingDate | 2013-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104224710-B |
| titleOfInvention | A kind of docetaxel nanometer micella, its preparation method and application |
| abstract | The invention discloses a kind of docetaxel nanometer micella, preparation method and its purposes in the medicine for the treatment of tumour or resistant tumors is prepared.The docetaxel nanometer micella includes：The parts by weight of docetaxel 1；The parts by weight of carrier material 10 100；Oily 0 10 parts by weight, wherein, the average grain diameter of the docetaxel nanometer micella is 10~200nm.Said preparation can greatly increase the water solubility of docetaxel and the stability of preparation, extend the circulation time of docetaxel in blood, reduce the toxic side effect of existing preparation, pass through EPR effects passive target to tumor tissues, so as to improve the antitumor curative effect of docetaxel, and the multidrug resistance of tumour can be overcome. |
| priorityDate | 2013-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.